March 2014, 16:409,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 25 Mar 2014
Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox
- Harold Bays
- … show all 1 hide
Among lean populations, cardiovascular disease (CVD) is rare. Among those with increased adiposity, CVD is the commonest cause of worldwide death. The “obesity paradox” describes seemingly contrary relationships between body fat and health/ill-health. Multiple obesity paradoxes exist, and include the anatomic obesity paradox, physiologic obesity paradox, demographic obesity paradox, therapeutic obesity paradox, cardiovascular event/procedure obesity paradox, and obesity treatment paradox. Adiposopathy (“sick fat”) is defined as adipocyte/adipose tissue dysfunction caused by positive caloric balance and sedentary lifestyle in genetically and environmentally susceptible individuals. Adiposopathy contributes to the commonest metabolic disorders encountered in clinical practice (high glucose levels, high blood pressure, dyslipidemia, etc.), all major CVD risk factors. Ockham's razor is a principle of parsimony which postulates that among competing theories, the hypothesis with the fewest assumptions is the one best selected. Ockham’s razor supports adiposopathy as the primary cause of most cases of adiposity-related metabolic diseases, which in turn helps resolve the obesity paradox.
This article is part of the Topical Collection on Cardiovascular Disease and Stroke
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Walker AR. Are health and ill-health lessons from hunter-gatherers currently relevant? Am J Clin Nutr. 2001;73:353–6.PubMed
World Health Organization. Obesity and overweight. 2003. http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf. Accessed 17 Jan 2014.
Centers for Disease Control and Prevention. Obesity and overweight. http://www.cdc.gov/nchs/fastats/overwt.htm (2013). Accessed 17 Jan 2014.
World Health Organization. Cardiovascular diseases. http://www.who.int/mediacentre/factsheets/fs317/en/ (2013). Accessed 17 Jan 2014.
Haslam D. Letter to the Editor. Re: The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. Br Med J. 2013;346:f1050.CrossRef
Ritz E. Metabolic syndrome - what we know and what we don’t know. J Am Soc Nephrol. 2007;18:1619–23.CrossRef
Vague J. La differenciation sexuelle, facteur determinant des formes de l’obesite. Presse Med. 1947;55:339.PubMed
Bays H, Abate N, Chandalia M. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Futur Cardiol. 2005;1:39–59.CrossRef
Alberti G, Zimmet P, Shaw J, Grundy S. The International Diabetes Federation consensus worldwide definition of the metabolic syndrome. 2006. https://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed 31 Jan 2014.
Appachi S, Kashyap SR. ‘Adiposopathy’ and cardiovascular disease: the benefits of bariatric surgery. Curr Opin Cardiol. 2013;28:540–6.PubMed
Seaman DR. Body mass index and musculoskeletal pain: is there a connection? Chiropr Man Ther. 2013;21:15.CrossRef
Gonzalez-Campoy JM, St Jeor ST, Castorino K, Ebrahim A, Hurley D, Jovanovic L, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. Endocr Pract. 2013;19(3):1–82.PubMedCrossRef
Seger JC, Horn HD, Westman EC, Lindquist R, Scinta W, Richardson LA et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians. 2013–2014. http://www.asbp.org/images/ADV-COPY_ASBPObeistyAlgorithmOctober2013.pdf. Accessed 31 Jan 2014. This is a comprehensive algorithm in obesity assessment and management.
Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring). 2010;18:1510–5.CrossRef
Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring). 2010;18:1524–31.CrossRef
Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment—a position paper of the Obesity Society and the American Society of Hypertension. Obesity (Silver Spring). 2013;21:8–24. This is an in-depth review of obesity and hypertension.CrossRef
Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, et al. Beyond BMI: the “metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health. 2014;14:14.PubMedCentralPubMedCrossRef
Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining obesity in Asians. Ann Acad Med Singap. 2009;38:66–9.PubMed
Blum A, Simsolo C, Sirchan R, Haiek S. “Obesity paradox” in chronic obstructive pulmonary disease. Isr Med Assoc J. 2011;13:672–5.PubMed
Bellows CF, Zhang Y, Simmons PJ, Khalsa AS, Kolonin MG. Influence of BMI on level of circulating progenitor cells. Obesity (Silver Spring). 2011;19:1722–6.CrossRef
Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2006;92:768–74.PubMedCentralPubMedCrossRef
Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22:5–13.CrossRef
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013. doi:10.1161/01.cir.0000437738.63853.7a
International Atherosclerosis Society. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia. Full report. 2013. http://www.athero.org/download/IASPPGuidelines_FullReport_20131011.pdf. Accessed 31 Jan 2014.
- Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Current Atherosclerosis Reports
- Online Date
- March 2014
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Diabetes mellitus
- Metabolic syndrome
- Obesity paradox
- Ockham’s razor
- Sick fat
- Industry Sectors
- Harold Bays (1)
- Author Affiliations
- 1. Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY, 40213, USA